Liabilities / Assets
78th percentile
Higher debt load relative to assets than 78% of similar nonprofits.
EIN 30-0752401 • 501(c)3 • Baltimore, MD
Profile
The arm foundation serves as the educational and information resource on issues fundamental to making gene and cell therapies, tissue-engineered products and other regenerative medicine treatments available to patients. By examining, quantifying, clarifying and informing stakeholders of the clinical and societal benefits of these therapies, as well as convening discussions to raise awareness about the sectors progress, challenges and results, the foundation accelerates patient access to safe, efficacious and potentially curative therapies.
Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.
Liabilities / Assets
78th percentile
Higher debt load relative to assets than 78% of similar nonprofits.
Liabilities / Revenue
91st percentile
Higher debt load relative to revenue than 91% of similar nonprofits.
Net Margin
8th percentile
Higher net margin than 8% of similar nonprofits.
Top Officer Pay
81st percentile
Higher top officer pay than 81% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
31st percentile
Faster asset growth than 31% of similar nonprofits.
Revenue Growth
98th percentile
Faster revenue growth than 98% of similar nonprofits.
Assets
Down$121,351
Down $32,780 (-21%) from 2022
Liabilities
Down$11,082
Down $1,301 (-11%) from 2022
Net Assets
Down$110,269
Down $31,479 (-22%) from 2022
Revenue
Up$25,000
Up $21,016 (+528%) from 2022
Expenses
Down$56,479
Down $12,831 (-19%) from 2022
Net Income
Up-$31,479
Up $33,847 (+52%) from 2022
Most recent year
2023 • Form 990EZDetailed filing. Detailed filing data is available for this year.
The arm foundation serves as the educational and information resource on issues fundamental to making gene and cell therapies, tissue-engineered products and other regenerative medicine treatments available to patients. By examining, quantifying, clarifying and informing stakeholders of the clinical and societal benefits of these therapies, as well as convening discussions to raise awareness about the sectors progress, challenges and results, the foundation accelerates patient access to safe, efficacious and potentially curative therapies.
| Description | Grants | Expenses |
|---|---|---|
| GENE MEDICINE EDUCATION - A STRATEGIC COMMUNICATIONS PROGRAM DESIGNED TO INCREASE AWARENESS AND UNDERSTANDING OF CELL AND GENE THERAPIES AS TRANSFORMATIVE MEDICINES AND IMPORTANT THERAPEUTIC OPTIONS FOR TREATING DISEASE AND EQUIP PEOPLE TO MAKE INFORMED DECISIONS ABOUT CELL AND GENE MEDICINE. THIS INFORMATION IS MADE AVAILABLE TO PATIENTS, CAREGIVERS, PROVIDERS, AND THE GENERAL PUBLIC. | - | $14,622 |
| EDUCATIONAL AND INFORMATION RESOURCE ON ISSUES FUNDAMENTAL TO MAKING GENE AND CELL THERAPIES, TISSUE-ENGINEERED PRODUCTS AND OTHER REGENERATIVE MEDICINE TREATMENTS AVAILABLE TO PATIENTS. | - | $3,432 |
| HEALTH & ECONOMIC IMPACT ANALYSIS - DEVELOP AN IN-DEPTH ANALYSIS OF CELL AND GENE THERAPY AND OTHER REGENERATIVE MEDICINES ON THE NATIONAL AND INTERNATIONAL HEALTHCARE ECONOMIES TO SUPPORT MARKET ACCESS INITIATIVES AND PUBLIC AWARENESS. COMMUNICATING THE SOCIETAL AND ECONOMIC VALUE OF RM THERAPIES THROUGH DATA REPORTING AND STRATEGIC ENGAGEMENT WITH HEALTHCARE PROVIDERS AND THE GENERAL PUBLIC. | - | $1,534 |
| CONVENING OF PATIENT GROUP LEADERSHIP WORKSHOP FOR ROUGHLY 25 LEADERS FROM THE PATIENT COMMUNITY TO DISCUSS INITIATIVES TO HELP THEM EDUCATE THEIR CONSTITUENTS ABOUT THE BENEFITS OF CELL AND GENE MEDICINE. | - | $1,263 |
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| BRETT KOPELAN | Chair | - | $0 | - | - |
| MARTHA ROOK | Treasurer | - | $0 | - | - |
| ADRIAN MCKEMEY | Secretary | - | $0 | - | - |
| NICOLE BOICE | Director | - | $0 | - | - |
| SARAH CREVISTON | Director | - | $0 | - | - |
| JILL ELLIOTT | Director | - | $0 | - | - |
| ELLEN FEIGAL | Director | - | $0 | - | - |
| PAT FURLONG | Director | - | $0 | - | - |
| DON GIBBONS | Director | - | $0 | - | - |
| CHRISTINA HARTMAN | Director | - | $0 | - | - |
| MICHAEL MAY | Director | - | $0 | - | - |
| MARIA MILLAN | Director | - | $0 | - | - |
| DAVID NAGLER | Director | - | $0 | - | - |
| EMILE NUWAYSIR | Director | - | $0 | - | - |
| STEWART PARKER | Director | - | $0 | - | - |
| DENNIS PURCELL | Director | - | $0 | - | - |
| BROCK REEVE | Director | - | $0 | - | - |
| MORRIE RUFFIN | Director | - | $0 | - | - |
| DAVID SMITH | Director | - | $0 | - | - |
| ROBERT SMITH | Director | - | $0 | - | - |
| PHIL VANEK | Director | - | $0 | - | - |
| JAMES VALENTINE | Director | - | $0 | - | - |
| MICHAEL WERNER | Director | - | $0 | - | - |
| CLAUDIA ZYLBERBERG | Director | - | $0 | - | - |
“Expenses advertising & marketing 479 general administrative ex 595 information technology ex 21,215 insurance 8,202 miscellaneous expenses 2,048 payroll processing 7,157 total 39,696”
“Accounts payable and accrued expenses 5,151 3,850 401k payable 7,232 7,232”
“The arm foundation serves as the educational and information resource on issues fundamental to making gene and cell therapies, tissue-engineered products and other regenerative medicine treatments available to patients. By examining, quantifying, clarifying and informing stakeholders of the clinical and societal benefits of these therapies, as well as convening discussions to raise awareness about the sectors progress, challenges and results, the foundation accelerates patient access to safe, efficacious and potentially curative therapies.”
“Gene medicine education - a strategic communications program designed to increase awareness and understanding of cell and gene therapies as transformative medicines and important therapeutic options for treating disease and equip people to make informed decisions about cell and gene medicine. This information is made available to patients, caregivers, providers, and the general public.”
“Health & economic impact analysis - develop an in-depth analysis of cell and gene therapy and other regenerative medicines on the national and international healthcare economies to support market access initiatives and public awareness. Communicating the societal and economic value of rm therapies through data reporting and strategic engagement with healthcare providers and the general public.”
“Convening of patient group leadership workshop for roughly 25 leaders from the patient community to discuss initiatives to help them educate their constituents about the benefits of cell and gene medicine.”
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BooksInCareOfDetail/PersonNm | 0 | ERIN CUMMINGS |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 2023453675 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 1340 SMITH AVENUE SUITE 200 |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | BALTIMORE |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | MD |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 21209 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt | 0 | 154131 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 121351 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | false |
| IRS990EZ/ContributionsGiftsGrantsEtcAmt | 0 | 25000 |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | -31479 |
| IRS990EZ/FeesAndOtherPymtToIndCntrctAmt | 0 | 345 |
| IRS990EZ/FiledScheduleAInd | 0 | true |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 154131 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 121351 |
| IRS990EZ/GrossReceiptsAmt | 0 | 25000 |
| IRS990EZ/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIInd | 0 | X |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | false |
| IRS990EZ/MethodOfAccountingAccrualInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesBOYAmt | 0 | 141748 |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | 110269 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 141748 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | 110269 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 0.48 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 3 | 0.19 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 4 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 5 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 6 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 7 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 8 | 0.38 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 9 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 10 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 11 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 12 | 0.15 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 13 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 14 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 15 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 16 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 17 | 0.15 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 18 | 0.15 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 19 | 0.15 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 20 | 0.19 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 21 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 22 | 0.10 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 23 | 0.12 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 4 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 5 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 6 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 7 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 8 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 9 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 10 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 11 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 12 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 13 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 14 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 15 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 16 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 17 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 18 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 19 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 20 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 21 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 22 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 23 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | BRETT KOPELAN |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | MARTHA ROOK |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | ADRIAN MCKEMEY |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 3 | NICOLE BOICE |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 4 | SARAH CREVISTON |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 5 | JILL ELLIOTT |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 6 | ELLEN FEIGAL |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 7 | PAT FURLONG |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 8 | DON GIBBONS |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 9 | CHRISTINA HARTMAN |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 10 | MICHAEL MAY |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 11 | MARIA MILLAN |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 12 | DAVID NAGLER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 13 | EMILE NUWAYSIR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 14 | STEWART PARKER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 15 | DENNIS PURCELL |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 16 | BROCK REEVE |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 17 | MORRIE RUFFIN |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 18 | DAVID SMITH |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 19 | ROBERT SMITH |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 20 | PHIL VANEK |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 21 | JAMES VALENTINE |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 22 | MICHAEL WERNER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 23 | CLAUDIA ZYLBERBERG |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | CHAIR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | TREASURER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | SECRETARY |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 3 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 4 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 5 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 6 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 7 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 8 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 9 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 10 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 11 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 12 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 13 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 14 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 15 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 16 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 17 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 18 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 19 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 20 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 21 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 22 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 23 | DIRECTOR |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 39696 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | THE ARM FOUNDATION SERVES AS THE EDUCATIONAL AND INFORMATION RESOURCE ON ISSUES FUNDAMENTAL TO MAKING GENE AND CELL THERAPIES, TISSUE-ENGINEERED PRODUCTS AND OTHER REGENERATIVE MEDICINE TREATMENTS AVAILABLE TO PATIENTS. BY EXAMINING, QUANTIFYING, CLARIFYING AND INFORMING STAKEHOLDERS OF THE CLINICAL AND SOCIETAL BENEFITS OF THESE THERAPIES, AS WELL AS CONVENING DISCUSSIONS TO RAISE AWARENESS ABOUT THE SECTORS PROGRESS, CHALLENGES AND RESULTS, THE FOUNDATION ACCELERATES PATIENT ACCESS TO SAFE, EFFICACIOUS AND POTENTIALLY CURATIVE THERAPIES. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | GENE MEDICINE EDUCATION - A STRATEGIC COMMUNICATIONS PROGRAM DESIGNED TO INCREASE AWARENESS AND UNDERSTANDING OF CELL AND GENE THERAPIES AS TRANSFORMATIVE MEDICINES AND IMPORTANT THERAPEUTIC OPTIONS FOR TREATING DISEASE AND EQUIP PEOPLE TO MAKE INFORMED DECISIONS ABOUT CELL AND GENE MEDICINE. THIS INFORMATION IS MADE AVAILABLE TO PATIENTS, CAREGIVERS, PROVIDERS, AND THE GENERAL PUBLIC. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 1 | EDUCATIONAL AND INFORMATION RESOURCE ON ISSUES FUNDAMENTAL TO MAKING GENE AND CELL THERAPIES, TISSUE-ENGINEERED PRODUCTS AND OTHER REGENERATIVE MEDICINE TREATMENTS AVAILABLE TO PATIENTS. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 2 | HEALTH & ECONOMIC IMPACT ANALYSIS - DEVELOP AN IN-DEPTH ANALYSIS OF CELL AND GENE THERAPY AND OTHER REGENERATIVE MEDICINES ON THE NATIONAL AND INTERNATIONAL HEALTHCARE ECONOMIES TO SUPPORT MARKET ACCESS INITIATIVES AND PUBLIC AWARENESS. COMMUNICATING THE SOCIETAL AND ECONOMIC VALUE OF RM THERAPIES THROUGH DATA REPORTING AND STRATEGIC ENGAGEMENT WITH HEALTHCARE PROVIDERS AND THE GENERAL PUBLIC. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 3 | CONVENING OF PATIENT GROUP LEADERSHIP WORKSHOP FOR ROUGHLY 25 LEADERS FROM THE PATIENT COMMUNITY TO DISCUSS INITIATIVES TO HELP THEM EDUCATE THEIR CONSTITUENTS ABOUT THE BENEFITS OF CELL AND GENE MEDICINE. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 0 | 14622 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 1 | 3432 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 2 | 1534 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 3 | 1263 |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/SalariesOtherCompEmplBnftAmt | 0 | 16438 |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt | 0 | 12383 |
| IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt | 0 | 11082 |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 56479 |
| IRS990EZ/TotalProgramServiceExpensesAmt | 0 | 20851 |
| IRS990EZ/TotalRevenueAmt | 0 | 25000 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990EZ/WebsiteAddressTxt | 0 | THEARMFOUNDATION.ORG |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt | 0 | 25000 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt | 0 | 3984 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 493318 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 959071 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 670750 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt | 0 | 2152123 |
| IRS990ScheduleA/PublicOrganization170Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY170Pct | 0 | 0.38520 |
| IRS990ScheduleA/PublicSupportPY170Pct | 0 | 0.38930 |
| IRS990ScheduleA/PublicSupportTotal170Amt | 0 | 828961 |
| IRS990ScheduleA/SubstantialContributorsTotAmt | 0 | 1323162 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind | 0 | X |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt | 0 | 25000 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt | 0 | 3984 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 493318 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 959071 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 670750 |
| IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt | 0 | 2152123 |
| IRS990ScheduleA/TotalSupportAmt | 0 | 2152123 |
| IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorNum | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine2 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt | 0 | RESTRICTED |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | EXPENSES ADVERTISING & MARKETING 479 GENERAL ADMINISTRATIVE EX 595 INFORMATION TECHNOLOGY EX 21,215 INSURANCE 8,202 MISCELLANEOUS EXPENSES 2,048 PAYROLL PROCESSING 7,157 TOTAL 39,696 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | ACCOUNTS PAYABLE AND ACCRUED EXPENSES 5,151 3,850 401K PAYABLE 7,232 7,232 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | THE ARM FOUNDATION SERVES AS THE EDUCATIONAL AND INFORMATION RESOURCE ON ISSUES FUNDAMENTAL TO MAKING GENE AND CELL THERAPIES, TISSUE-ENGINEERED PRODUCTS AND OTHER REGENERATIVE MEDICINE TREATMENTS AVAILABLE TO PATIENTS. BY EXAMINING, QUANTIFYING, CLARIFYING AND INFORMING STAKEHOLDERS OF THE CLINICAL AND SOCIETAL BENEFITS OF THESE THERAPIES, AS WELL AS CONVENING DISCUSSIONS TO RAISE AWARENESS ABOUT THE SECTORS PROGRESS, CHALLENGES AND RESULTS, THE FOUNDATION ACCELERATES PATIENT ACCESS TO SAFE, EFFICACIOUS AND POTENTIALLY CURATIVE THERAPIES. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | GENE MEDICINE EDUCATION - A STRATEGIC COMMUNICATIONS PROGRAM DESIGNED TO INCREASE AWARENESS AND UNDERSTANDING OF CELL AND GENE THERAPIES AS TRANSFORMATIVE MEDICINES AND IMPORTANT THERAPEUTIC OPTIONS FOR TREATING DISEASE AND EQUIP PEOPLE TO MAKE INFORMED DECISIONS ABOUT CELL AND GENE MEDICINE. THIS INFORMATION IS MADE AVAILABLE TO PATIENTS, CAREGIVERS, PROVIDERS, AND THE GENERAL PUBLIC. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | HEALTH & ECONOMIC IMPACT ANALYSIS - DEVELOP AN IN-DEPTH ANALYSIS OF CELL AND GENE THERAPY AND OTHER REGENERATIVE MEDICINES ON THE NATIONAL AND INTERNATIONAL HEALTHCARE ECONOMIES TO SUPPORT MARKET ACCESS INITIATIVES AND PUBLIC AWARENESS. COMMUNICATING THE SOCIETAL AND ECONOMIC VALUE OF RM THERAPIES THROUGH DATA REPORTING AND STRATEGIC ENGAGEMENT WITH HEALTHCARE PROVIDERS AND THE GENERAL PUBLIC. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 5 | CONVENING OF PATIENT GROUP LEADERSHIP WORKSHOP FOR ROUGHLY 25 LEADERS FROM THE PATIENT COMMUNITY TO DISCUSS INITIATIVES TO HELP THEM EDUCATE THEIR CONSTITUENTS ABOUT THE BENEFITS OF CELL AND GENE MEDICINE. |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990-EZ, PART I, LINE 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990-EZ, PART II, LINE 26 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990-EZ, PART III |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990-EZ, PART III, LINE 28 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | FORM 990-EZ, PART III, LINE 30 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 5 | FORM 990-EZ, PART III, LINE 31 |
| ReturnHeader/BuildTS | 0 | 2024-10-15 13:58:12Z |
| ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd | 0 | true |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | BRETT KOPELAN |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | CHAIR |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 2023453675 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2024-10-17 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | ARM FOUNDATION FOR REGENERATIVE |
| ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt | 0 | MEDICINE EDUCATION & RESEARCH |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | ARMF |
| ReturnHeader/Filer/EIN | 0 | 300752401 |
| ReturnHeader/Filer/PhoneNum | 0 | 2023453675 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 1340 SMITH AVENUE SUITE 200 |
| ReturnHeader/Filer/USAddress/CityNm | 0 | BALTIMORE |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | MD |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 21209 |
| ReturnHeader/IRSResponsiblePrtyInfoCurrInd | 0 | true |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 274760605 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | KULLMAN CPA LLC |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 888 BESTGATE ROAD SUITE 316 |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | ANNAPOLIS |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | MD |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 21401 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 4102669885 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2024-10-17 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | STEPHEN J KULLMAN CPA |
| ReturnHeader/ReturnTs | 0 | 2024-11-11T12:13:57-05:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2023-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2023-12-31 |
| ReturnHeader/TaxYr | 0 | 2023 |
No mirrored PDF or thumbnail assets are attached yet.